Company: BIVIW
Filing Date: 2025-08-04
Form Type: S-1/A
Source: 0001520138-25-000235
Chunk: 208

Company: BIOVIE INC.
Filing Date: 2025-08-04
Form: S-1/A
Chunk 208
---
000. Total interest expense associated with the Loan for the nine months ended March 31, 2024 was approximately
$2.5 million on the accompanying condensed statements of operations and comprehensive loss. Interest expense was comprised of interest
incurred on the outstanding principal of the loan of approximately $1.3 million, amortization of financing costs of approximately $92,000,
amortization of the unearned discount of approximately $867,000 and the accretion of Loan Premium of approximately $201,000.

The following is a summary of the Notes Payable as of March 31, 2025 and
June 30, 2024:

| Schedule of note payable                                                                |     | March 31, 2025 |   |     | June 30, 2024 |           |   |
|:----------------------------------------------------------------------------------------|:----|:---------------|:--|:----|:--------------|----------:|:--|
| Current portion of Notes Payable                                                        |     | $              | - |     | $             | 5,000,000 |   |
| Less: debt financing costs                                                              |     |                | - |     |               |   (11,820 | ) |
| Less: unearned discount                                                                 |     |                | - |     |               |  (111,212 | ) |
| Plus: accretion of Loan Premium                                                         |     |                | - |     |               |   824,242 |   |
| Current portion of Notes Payable, net of financing costs, unearned premium and discount |     | $              | - |     | $             | 5,701,210 |   |

| 7. | Fair Value Measurements |

The Company’s derivative liabilities during the nine months ended
March 31, 2025 related to the Avenue Warrants is a level 3 liability measured at fair value.

The fair value of the Avenue Warrants at March 31, 2025, in the accompanying
condensed balance sheets, was nil. The total change in the fair value of the derivative liabilities totaled approximately $3,771 and $1.8
million for the nine months ended March 31, 2025 and 2024, respectively, and approximately $7,290 and $109,000 for the three months ended March
31, 2025 and 2024, respectively; and accordingly, was recorded in the accompanying condensed statements
of operations and comprehensive loss. The assumptions used in the